The production of retatrutide, a novel dual stimulant targeting both GLP-1 and GIP receptors, requires a complex complicated chemical process. Early routes focused on protein portion coupling, utilizing solid-phase synthesis methodologies to build the long peptide sequence. Subsequent study has e